1. Home
  2. EVO vs UPBD Comparison

EVO vs UPBD Comparison

Compare EVO & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • UPBD
  • Stock Information
  • Founded
  • EVO 1993
  • UPBD 1986
  • Country
  • EVO Germany
  • UPBD United States
  • Employees
  • EVO N/A
  • UPBD N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • UPBD Diversified Commercial Services
  • Sector
  • EVO Health Care
  • UPBD Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • UPBD Nasdaq
  • Market Cap
  • EVO 1.5B
  • UPBD 1.6B
  • IPO Year
  • EVO 2021
  • UPBD 1995
  • Fundamental
  • Price
  • EVO $4.11
  • UPBD $29.54
  • Analyst Decision
  • EVO Buy
  • UPBD Buy
  • Analyst Count
  • EVO 2
  • UPBD 6
  • Target Price
  • EVO $5.90
  • UPBD $39.17
  • AVG Volume (30 Days)
  • EVO 184.0K
  • UPBD 484.2K
  • Earning Date
  • EVO 11-06-2024
  • UPBD 02-20-2025
  • Dividend Yield
  • EVO N/A
  • UPBD 5.08%
  • EPS Growth
  • EVO N/A
  • UPBD 833.06
  • EPS
  • EVO N/A
  • UPBD 1.49
  • Revenue
  • EVO $866,665,179.00
  • UPBD $4,259,426,999.00
  • Revenue This Year
  • EVO $3.89
  • UPBD $9.86
  • Revenue Next Year
  • EVO $9.65
  • UPBD $4.72
  • P/E Ratio
  • EVO N/A
  • UPBD $19.81
  • Revenue Growth
  • EVO N/A
  • UPBD 7.43
  • 52 Week Low
  • EVO $2.85
  • UPBD $26.50
  • 52 Week High
  • EVO $8.39
  • UPBD $38.72
  • Technical
  • Relative Strength Index (RSI)
  • EVO 42.87
  • UPBD 44.07
  • Support Level
  • EVO $4.00
  • UPBD $29.14
  • Resistance Level
  • EVO $4.63
  • UPBD $29.91
  • Average True Range (ATR)
  • EVO 0.14
  • UPBD 0.77
  • MACD
  • EVO -0.04
  • UPBD 0.13
  • Stochastic Oscillator
  • EVO 16.88
  • UPBD 68.34

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: